The aim of the study is to examine the effectiveness of arthrocentesis plus tenoxicam injection and to compare it with arthrocentesis alone in patients with TMJ-OA. Thirty patients with TMJ-OA who were treated randomly with either arthrocentesis plus tenoxicam injection (TX group) or arthrocentesis alone (control group) were examined. Maximum mouth opening (MMO), visual analog scale (VAS) pain values, and joint sounds were the outcome variables, which were evaluated at pre-treatment and at 1, 4, 12, and 24 weeks after treatment.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Pain on Tmj (Visual analog scale(VAS) was used.)
Timeframe: Change from baseline pain on TMJ at six months
Maximum Mouth Opening(MMO) (A ruler was used)
Timeframe: Change from baseline maximum mouth opening at six months
Joint sounds (Visual analog scale was used to measure.)
Timeframe: Change from baseline joint sounds at six months